Drug intelligence / Profile preview

GeneXSTEM

Development stage
Phase 2
Lead developer
BioIntegrate
Modality
Gene Therapies, Stem Cell Therapies → Cell Therapies
Administration
Intraarticular
01

Overview

GeneXSTEM (GXS-001) is an autologous, gene-modified mesenchymal stem cell (MSC) therapy developed by GeneXstem Inc. for the treatment of degenerative joint diseases, specifically knee osteoarthritis. The therapy utilizes the patient's own adipose-derived stem cells, which are harvested and then genetically modified using a proprietary gene-delivery system to enhance their therapeutic potential. These modified cells are designed to overexpress specific growth factors or anti-inflammatory proteins that promote the regeneration of damaged cartilage and modulate the intra-articular inflammatory environment. By delivering a sustained therapeutic effect directly to the joint, GeneXSTEM aims to reduce pain, improve joint function, and potentially reverse the progression of osteoarthritis, offering a regenerative alternative to conventional symptomatic treatments.

Other names
GeneXstem therapyGeneXstem stem cell therapy

Beyond the preview

Go deeper on GeneXSTEM.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on GeneXSTEM.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call